CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Restructuring Charges
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Restructuring Charges of $23.06 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-05
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. restructuring charges for the quarter ending 2026-06-27 was $23.06M, a 28.39% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. restructuring charges for the quarter ending 2026-03-28 was $31.58M, a 32.44% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. restructuring charges for the quarter ending 2025-12-27 was $26.49M, a 36.00% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. restructuring charges for the quarter ending 2025-09-27 was $17.28M, a 43.60% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. restructuring charges for fiscal 2025 was $99.81M, a 6.70% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. restructuring charges for fiscal 2024 was $106.98M, a 260.44% increase from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. restructuring charges for fiscal 2023 was $29.68M, a 261.40% increase from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. restructuring charges for fiscal 2022 was $8.21M, a 19.79% increase from fiscal 2021.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 6 month as first filed | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-27 | $23.06M 10-Q · filed 2026-08-05 | $54.64M 10-Q · filed 2026-08-05 | $81.12M derived: sum of 3 quarters · filed 2026-08-05 | $98.41M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-28 | $31.58M 10-Q · filed 2026-05-07 | $58.07M derived: sum of 2 quarters · filed 2026-05-07 | $75.35M derived: sum of 3 quarters · filed 2026-05-07 | $107.55M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-27 | $26.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $43.77M derived: sum of 2 quarters · filed 2026-02-18 | $75.97M derived: sum of 3 quarters · filed 2026-08-05 | $99.81M 10-K · filed 2026-02-18 | ||||
| 2025-09-27 | $17.28M 10-Q · filed 2025-11-05 | $49.48M derived: sum of 2 quarters · filed 2026-08-05 | $73.33M 10-Q · filed 2025-11-05 | $114.71M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-28 | $32.20M 10-Q · filed 2026-08-05 | $56.05M 10-Q · filed 2026-08-05 | $97.43M derived: sum of 3 quarters · filed 2026-08-05 | $128.08M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-29 | $23.84M 10-Q · filed 2026-05-07 | $65.23M derived: sum of 2 quarters · filed 2026-05-07 | $95.88M derived: sum of 3 quarters · filed 2026-05-07 | $113.83M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-28 | $41.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $72.03M derived: sum of 2 quarters · filed 2026-02-18 | $89.99M derived: sum of 3 quarters · filed 2026-02-18 | $106.98M 10-K · filed 2026-02-18 | ||||
| 2024-09-28 | $30.65M 10-Q · filed 2025-11-05 | $48.60M derived: sum of 2 quarters · filed 2025-11-05 | $65.60M 10-Q · filed 2025-11-05 | $73.94M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-06-29 | $17.95M 10-Q · filed 2025-08-06 | $34.95M 10-Q · filed 2025-08-06 | $43.29M derived: sum of 3 quarters · filed 2026-02-18 | $58.45M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2024-03-30 | $17.00M 10-Q · filed 2025-05-07 | $25.34M derived: sum of 2 quarters · filed 2026-02-18 | $40.50M derived: sum of 3 quarters · filed 2026-02-18 | $43.20M derived: sum of 4 quarters · filed 2026-02-18 | ||||
| 2023-12-30 | $8.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $23.50M derived: sum of 2 quarters · filed 2026-02-18 | $26.20M derived: sum of 3 quarters · filed 2026-02-18 | $29.68M 10-K · filed 2026-02-18 | ||||
| 2023-09-30 | $15.16M 10-Q · filed 2024-11-06 | $17.86M derived: sum of 2 quarters · filed 2024-11-06 | $21.34M 10-Q · filed 2024-11-06 | $25.08M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-07-01 | $2.70M 10-Q · filed 2024-08-07 | $6.18M 10-Q · filed 2024-08-07 | $9.92M derived: sum of 3 quarters · filed 2025-02-19 | $11.02M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-04-01 | $3.49M 10-Q · filed 2024-05-09 | $7.22M derived: sum of 2 quarters · filed 2025-02-19 | $8.32M derived: sum of 3 quarters · filed 2025-02-19 | $9.69M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | $3.73M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $4.84M derived: sum of 2 quarters · filed 2025-02-19 | $6.20M derived: sum of 3 quarters · filed 2025-02-19 | $8.21M 10-K · filed 2025-02-19 | ||||
| 2022-09-24 | $1.10M 10-Q · filed 2023-11-08 | $2.47M derived: sum of 2 quarters · filed 2023-11-08 | $4.48M 10-Q · filed 2023-11-08 | $6.64M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-25 | $1.36M 10-Q · filed 2022-08-03 | $3.38M 10-Q · filed 2022-08-03 | $5.54M derived: sum of 3 quarters · filed 2024-02-14 | $7.87M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-26 | $2.01M 10-Q · filed 2022-05-04 | $4.18M derived: sum of 2 quarters · filed 2024-02-14 | $6.51M derived: sum of 3 quarters · filed 2024-02-14 | $8.12M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-25 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $4.50M derived: sum of 2 quarters · filed 2024-02-14 | $6.11M derived: sum of 3 quarters · filed 2024-02-14 | $6.86M 10-K · filed 2024-02-14 | ||||
| 2021-09-25 | $2.33M 10-Q · filed 2022-11-02 | $3.94M derived: sum of 2 quarters · filed 2022-11-02 | $4.69M 10-Q · filed 2022-11-02 | $6.79M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-26 | $1.61M 10-Q · filed 2022-08-03 | $2.36M 10-Q · filed 2022-08-03 | $4.46M derived: sum of 3 quarters · filed 2023-02-22 | $6.04M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-27 | $749.00K 10-Q · filed 2022-05-04 | $2.85M derived: sum of 2 quarters · filed 2023-02-22 | $4.43M derived: sum of 3 quarters · filed 2023-02-22 | $12.79M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-26 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $3.69M derived: sum of 2 quarters · filed 2023-02-22 | $12.04M derived: sum of 3 quarters · filed 2023-02-22 | $12.59M 10-K · filed 2023-02-22 | ||||
| 2020-09-26 | $1.58M 10-Q · filed 2021-11-03 | $9.93M derived: sum of 2 quarters · filed 2021-11-03 | $10.49M 10-Q · filed 2021-11-03 | $18.44M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-27 | $8.35M 10-Q · filed 2021-08-04 | $8.91M 10-Q · filed 2021-08-04 | $16.86M derived: sum of 3 quarters · filed 2022-02-16 | $19.52M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-28 | $559.00K 10-Q · filed 2021-05-04 | $8.51M derived: sum of 2 quarters · filed 2022-02-16 | $11.16M derived: sum of 3 quarters · filed 2022-02-16 | $12.85M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-28 | $7.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $10.61M derived: sum of 2 quarters · filed 2022-02-16 | $12.29M derived: sum of 3 quarters · filed 2022-02-16 | $13.84M 10-K · filed 2022-02-16 | ||||
| 2019-09-28 | $2.65M 10-Q · filed 2020-10-29 | $4.34M derived: sum of 2 quarters · filed 2020-10-29 | $5.89M 10-Q · filed 2020-10-29 | $8.27M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-06-29 | $1.69M 10-Q · filed 2020-08-05 | $3.23M 10-Q · filed 2020-08-05 | $5.62M derived: sum of 3 quarters · filed 2021-02-17 | $10.29M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2019-03-30 | $1.55M 10-Q · filed 2020-05-07 | $3.93M derived: sum of 2 quarters · filed 2021-02-17 | $8.61M derived: sum of 3 quarters · filed 2021-02-17 | $10.46M derived: sum of 4 quarters · filed 2021-02-17 | ||||
| 2018-12-29 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $7.06M derived: sum of 2 quarters · filed 2021-02-17 | $8.91M derived: sum of 3 quarters · filed 2021-02-17 | $9.55M 10-K · filed 2021-02-17 | $7.57M 10-K · filed 2019-02-13 | |||
| 2018-09-29 | $4.67M 10-Q · filed 2019-11-06 | $6.53M derived: sum of 2 quarters · filed 2019-11-06 | $7.17M 10-Q · filed 2019-11-06 | $9.49M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2018-06-30 | $1.86M 10-Q · filed 2019-07-31 | $2.49M 10-Q · filed 2019-07-31 | $4.81M derived: sum of 3 quarters · filed 2020-02-11 | $5.72M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2018-03-31 | $638.00K 10-Q · filed 2019-05-07 | $2.96M derived: sum of 2 quarters · filed 2020-02-11 | $3.87M derived: sum of 3 quarters · filed 2020-02-11 | $4.34M derived: sum of 4 quarters · filed 2020-02-11 | ||||
| 2017-12-30 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-11 | $3.23M derived: sum of 2 quarters · filed 2020-02-11 | $3.70M derived: sum of 3 quarters · filed 2020-02-11 | $4.78M 10-K · filed 2020-02-11 | ||||
| 2017-09-30 | $912.00K 10-Q · filed 2018-11-07 | $690.00K 10-Q · filed 2017-11-09 | $1.38M derived: sum of 2 quarters · filed 2018-11-07 | $2.46M 10-Q · filed 2018-11-07 | $2.90M 10-Q · filed 2017-11-09 | $12.21M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-07-01 | $472.00K 10-Q · filed 2018-08-08 | $1.19M 10-Q · filed 2017-08-09 | $1.55M 10-Q · filed 2018-08-08 | $2.21M 10-Q · filed 2017-08-09 | $11.29M derived: sum of 3 quarters · filed 2019-02-13 | $15.31M derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-04-01 | $1.08M 10-Q · filed 2018-05-10 | $1.02M 10-Q · filed 2017-05-10 | $10.82M derived: sum of 2 quarters · filed 2019-02-13 | $14.84M derived: sum of 3 quarters · filed 2019-02-13 | $18.93M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | $9.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $13.76M derived: sum of 2 quarters · filed 2019-02-13 | $17.86M derived: sum of 3 quarters · filed 2019-02-13 | $17.88M 10-K · filed 2019-02-13 | $8.45M 10-K · filed 2017-02-14 | |||
| 2016-09-24 | $4.01M 10-Q · filed 2017-11-09 | $8.11M derived: sum of 2 quarters · filed 2017-11-09 | $8.13M 10-Q · filed 2017-11-09 | |||||
| 2016-06-25 | $4.10M 10-Q · filed 2017-08-09 | $4.12M 10-Q · filed 2017-08-09 | ||||||
| 2016-03-26 | $21.00K 10-Q · filed 2017-05-10 | |||||||
| 2015-12-26 | $8.01M 10-K · filed 2018-02-13 | $6.17M 10-K · filed 2017-02-14 | ||||||
| 2015-06-27 | $705.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $1.83M 10-Q · filed 2015-07-30 | $4.26M derived: sum of 3 quarters · filed 2017-02-14 | $4.84M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-28 | $1.13M 10-Q · filed 2015-04-30 | $3.56M derived: sum of 2 quarters · filed 2017-02-14 | $4.13M derived: sum of 3 quarters · filed 2017-02-14 | $7.02M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-27 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $3.00M derived: sum of 2 quarters · filed 2017-02-14 | $5.89M derived: sum of 3 quarters · filed 2017-02-14 | $7.79M 10-K · filed 2017-02-14 | ||||
| 2014-09-27 | $574.00K 10-Q · filed 2014-10-30 | $3.46M derived: sum of 2 quarters · filed 2014-10-30 | $5.36M 10-Q · filed 2014-10-30 | $7.53M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2014-06-28 | $2.89M 10-Q · filed 2014-08-07 | $4.79M 10-Q · filed 2014-08-07 | $6.95M derived: sum of 3 quarters · filed 2015-02-17 | $7.43M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2014-03-29 | $1.90M 10-Q · filed 2014-04-30 | $4.07M derived: sum of 2 quarters · filed 2015-02-17 | $4.54M derived: sum of 3 quarters · filed 2015-02-17 | $4.83M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-12-28 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $2.64M derived: sum of 2 quarters · filed 2015-02-17 | $2.93M derived: sum of 3 quarters · filed 2015-02-17 | $3.22M 10-K · filed 2015-02-17 | ||||
| 2013-09-28 | $476.00K 10-Q · filed 2014-10-30 | $761.00K derived: sum of 2 quarters · filed 2014-10-30 | $1.06M 10-Q · filed 2014-10-30 | $1.75M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-06-29 | $285.00K 10-Q · filed 2014-08-07 | $582.00K 10-Q · filed 2014-08-07 | $1.28M derived: sum of 3 quarters · filed 2015-02-17 | $2.25M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-03-30 | $297.00K 10-Q · filed 2014-04-30 | $992.00K derived: sum of 2 quarters · filed 2015-02-17 | $1.96M derived: sum of 3 quarters · filed 2015-02-17 | $1.96M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2012-12-29 | $695.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $1.67M derived: sum of 2 quarters · filed 2015-02-17 | $1.67M derived: sum of 3 quarters · filed 2015-02-17 | $2.58M 10-K · filed 2015-02-17 | ||||
| 2012-09-29 | $970.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $970.00K derived: sum of 2 quarters · filed 2013-10-30 | $1.88M 10-Q · filed 2013-10-30 | |||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $911.00K 10-Q · filed 2013-07-31 | ||||||
| 2012-03-31 | $911.00K 10-Q · filed 2013-05-08 | |||||||
| 2011-12-31 | $5.46M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |